In this issue:
Sublobar resection for peripheral stage 1A NSCLC
Severe malnutrition risks postoperative death in gastrointestinal cancers
OFFER: olanzapine + standard triple antiemetic prevents CINV
Front-line gefitinib + chemo for EGFR-mutant NSCLC with brain metastases
Durable clinical benefit of neoadjuvant nivolumab in NSCLC
Second-line pembrolizumab for advanced HCC
Adjuvant EGFR-TKI therapy in EGFR mutated NSCLC
No survival benefit to neoadjuvant erlotinib vs chemo in EGFR+ NSCLC
Nivolumab plus temozolomide for NENs
Epirubicin–paclitaxel promising for relapsed SCLC
Please login below to download this issue (PDF)